期刊文献+

老年人肺癌的早期诊断和治疗策略 被引量:4

原文传递
导出
摘要 近年来的流行病学调查数据显示,肺癌已经成为我国癌症发病率和死亡率上升最快的恶性肿瘤。目前在我国,尤其是城市地区,肺癌的发病率和死亡率已占首位。而随着人口预期寿命的延长,我国正逐步进入老龄化社会,
作者 陈小东
出处 《中华临床医师杂志(电子版)》 CAS 2013年第21期4-6,共3页 Chinese Journal of Clinicians(Electronic Edition)
  • 相关文献

参考文献12

  • 1Henschke CI,McCauley DI,Yankelevitz DF. Early Lung Cancer Action Project:overall design and findings from baseline screening[J].{H}LANCET,1999.99-105.
  • 2Yu IT,Tse LA,Leung CC. Lung cancer mortality among silicotic workers in Hong Kong--no evidence for a link[J].{H}ANNALS OF ONCOLOGY,2007.1056-1063.
  • 3Jang TW,Oak CH,Chun BK. Detection of pre-invasive endobronchial tumors with D-light/autofluorescence system[J].{H}Journal of Korean Medical Science,2006.242-246.
  • 4The Elderly Lung Cancer Vinorelbine Italian Study Group. Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer[J].{H}JOURNAL OF THE NATIONAL CANCER INSTITUTE,1999.66-72.
  • 5Kudoh S,Takeda K,Nakagawa K. Phase Ⅲ study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer:results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904)[J].{H}Journal of Clinical Oncology,2006.3657-3663.
  • 6Frasci G,Lorusso V,Panza N. Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer[J].{H}Journal of Clinical Oncology,2000.2529-2536.
  • 7Gridelli C,Perrone F,Gallo C. Chemotherapy for elderly patients with advanced non-small-cell lung cancer:the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase Ⅲ randomized trial[J].{H}JOURNAL OF THE NATIONAL CANCER INSTITUTE,2003.362-372.
  • 8Quoix E,Zalcman G,Oster JP. Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer:IFCT-0501 randomised,phase 3 trial[J].{H}LANCET,2011.1079-1088.
  • 9Crino L,Cappuzzo F,Zatloukal P. Gefitinib versus vinorelbine in chemotherapy-naive elderly patients with advanced non-small-cell lung cancer (INVITE):a randomized,phase Ⅱ study[J].{H}Journal of Clinical Oncology,2008.4253-4260.
  • 10Jackman DM,Yeap BY,Lindeman NI. Phase Ⅱ clinical trial of chemotherapy-naive patients》or=70 years of age treated with erlotinib for advanced non-small-cell lung cancer[J].{H}Journal of Clinical Oncology,2007.760-766.

同被引文献30

  • 1Owonikoko TK, Ragin CC, Belmfi CP, et al. Lung cancer in elder- ly patients: an mlalysis of the surveillance, epidenfiology, and end results database[J]. Clin Oncol, 2007, 25(35):5570-5577.
  • 2Nugent WC, Edney MT, Hammerness PG, et al. Non small cell lung cancer at the extremes of age:impact on diagnosis and treat- ment[J]. Ann Thorac Surg, 1997, 63(1):193-197.
  • 3Ginsberg RJ, Rubinstehl LV. Randomized trial of Iobectomy ver- sus limited resection for YINo nml-small cell lung cancer:Lung Cancer Study Group[J]. Ann Thorae Surg, 1995, 60(3):615-622.
  • 4Quoix E, Zalcman G, OsterJP, et al. Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial[J]. Lancet, 2011, 378(9796):1079-1088.
  • 5Whitson BA, Groth SS, Andrade RS, et al. Survival after lobectomy versus segmentectomy for stage I non-small cell lung cancer: a population-based analysis[J]. Ann Thorac Surg, 2011, 92(19):43-50.
  • 6Sirbu H, Schreiner W, Dalichan H, et al. Surgery for non-small cell carcinoma in geriatric patients: 15-year experience[J]. Asian Cardiovasc Thorac Ann, 2005, 13 (4) :330-336.
  • 7Schuchert MJ, Kilic A, Pennathur A, et al. Oncologic outcomes af- surgical resection of subcentimeter non-small cell lung cancer [J]. Ann Thorac Surg, 2011, 91(6):1681-1687.
  • 8Rami-Porta R, Ball D, CrowleyJ, et al. The IASLC Lung Cancer Staging Project proposals for the revision of the T descriptors in the forthcoming(seventh)edition of the TNM classification for lung cancer[J]. Thoracic Oncol, 2007, 2(7):593-602.
  • 9Yendamuri S, Shanna R, Demmy M, et al. Temporal trends in out- comes following sublobar and lobar resections for small (≤ 2 cm) non-small cel/lung cancers-a Surveillance Epidemiology End Re- sults database analysis[J]. Surg Res, 2013, 183(1):27-32.
  • 10Fan J, Wang L, Jiang GN, et al. Sublobectomy versus lobectomy for stage I non-smaLl-cell lung cancer, a meta-analysis of pub- lished studies[J]. Ann Surg Oncol, 2012, 19(2):661-668.

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部